AA. Abnormal and prolonged contraction of muscles of eyes, face, neck, limbs, or trunk developing in association with medication use B. Symptoms developed within a few days of starting or raising dose of medication, or reducing medication used to treat extrapyramidal symptoms
BA. Involuntary movements (tardive dystonia: sustained/repetitive muscle contractions; tardive akathisia: subjective restlessness + repetitive movements) developing in association with neuroleptic use, persisting ≥4 weeks B. Movements persist after neuroleptic dose reduction or discontinuation; or neuroleptic still required and symptoms are persistent